
Biotech firm gets US$33M boost for Ottawa-developed COVID-19 vaccine targeting new variants
Massachusetts-based VBI Vaccines began clinical trials at the Ottawa Hospital this week on the first version of its product.

Biotech firm gets US$33M boost for Ottawa-developed COVID-19 vaccine targeting new variants
Massachusetts-based VBI Vaccines began clinical trials at the Ottawa Hospital this week on the first version of its product.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored


Building Canada’s Defence Innovation Hub

6 Easy Maintenance Tips For Garage Door in Ottawa
